The epidemiology and clinical characteristics of myeloproliferative neoplasms in Malaysia-Reference-Cited by-同舟云学术

The epidemiology and clinical characteristics of myeloproliferative neoplasms in Malaysia

Published:2018-12 Issue:1 Volume:7 Page:
ISSN:2162-3619
Container-title:Experimental Hematology & Oncology
language:en
Short-container-title:Exp Hematol Oncol

Author:

Yap Yee Yee^ORCID,Law Kian Boon,Sathar Jameela,Lau Ngee Siang,Goh Ai Sim,Chew Teng Keat,Lim Soo Min,Menon Padmini,Guan Yong Khee,Husin Azlan Bin,Wong Lily Lee Lee,Chew Lee Ping,Salleh Sinari,Goh Kim Yen,Leong Kin Wah,Tan Sen Mui,Ong Tee Chuan,Lim Su Hong,Toh See Guan,Han Xavier Sim Yoon,Edmund Syed Carlo,Tan Jenq Tzong,Chang Kian Meng

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/s40164-018-0124-7.pdf

Reference36 articles.

1. Michiels JJ, Berneman Z, Schroyens W, De Raeve H. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond. Acta Haematol. 2015;133(1):36–51.

2. Hultcrantz M, Kristinsson SY, Andersson TM-L, Landgren O, Eloranta S, Derolf ÅR, et al. Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study. J Clin Oncol. 2012;30(24):2995–3001.

3. Skoda RC, Duek A, Grisouard J. Pathogenesis of myeloproliferative neoplasms. Exp Hematol. 2015;43(8):599–608.

4. Spivak JL. Myeloproliferative neoplasms. N Engl J Med. 2017;376(22):2168–81.

5. Ha J-S, Kim Y-K, Jung S-I, Jung H-R, Chung I-S. Correlations between janus kinase 2 V617F allele burdens and clinicohematologic parameters in myeloproliferative neoplasms. Ann Lab Med. 2012;32(6):385–91.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review About the Assessment of the Bleeding and Thrombosis Risk for Patients With Myeloproliferative Neoplasms Scheduled for Surgery;Cureus;2024-03-12

2. Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group;Clinical and Experimental Medicine;2023-09-25

3. Calreticulin Mutations in Myeloproliferative Neoplasms Patients Diagnosed in UKM Medical Centre;MARCH 2023;2023-03-13

4. Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review;Biomedicines;2023-01-28

5. The Sarawak Myelofibrosis (SaMy) experience: Demographics and outcome of myelofibrosis patients in Sarawak, Malaysia;SAGE Open Medicine;2023-01